OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Current concepts of anti-EGFR targeting in metastatic colorectal cancer
Bernhard Doleschal, Andreas Petzer, Holger Rumpold
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Bernhard Doleschal, Andreas Petzer, Holger Rumpold
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Showing 17 citing articles:
Immune Checkpoint Inhibitor-Based Combination Therapy for Colorectal Cancer: An Overview
Jingjing Li, Xuan-Fu Xu
International Journal of General Medicine (2023) Vol. Volume 16, pp. 1527-1540
Open Access | Times Cited: 11
Jingjing Li, Xuan-Fu Xu
International Journal of General Medicine (2023) Vol. Volume 16, pp. 1527-1540
Open Access | Times Cited: 11
Epidermal Growth Factor Receptor Targeting in Colorectal Carcinoma: Antibodies and Patient-Derived Organoids as a Smart Model to Study Therapy Resistance
Samuele Tardito, Serena Matis, Maria Raffaella Zocchi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7131-7131
Open Access | Times Cited: 4
Samuele Tardito, Serena Matis, Maria Raffaella Zocchi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7131-7131
Open Access | Times Cited: 4
Efficacy and Safety of Anti-EGFR Therapy Rechallenge in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
Francisco Cézar Aquino de Moraes, Anna Luíza Soares de Oliveira Rodrigues, Jonathan N. Priantti, et al.
Journal of Gastrointestinal Cancer (2024) Vol. 56, Iss. 1
Closed Access | Times Cited: 4
Francisco Cézar Aquino de Moraes, Anna Luíza Soares de Oliveira Rodrigues, Jonathan N. Priantti, et al.
Journal of Gastrointestinal Cancer (2024) Vol. 56, Iss. 1
Closed Access | Times Cited: 4
Correlation Between Interleukin IL-6/IL-6 Receptor Polymorphisms (IL6–174C>G and IL6R 1073A>C) and RAS/BRAF Mutations in Patients with Colorectal Cancer
Ekaterina Smagina, Dar’ya Polit’ko, Vadim Kumeiko, et al.
Gastroenterology Insights (2025) Vol. 16, Iss. 1, pp. 6-6
Open Access
Ekaterina Smagina, Dar’ya Polit’ko, Vadim Kumeiko, et al.
Gastroenterology Insights (2025) Vol. 16, Iss. 1, pp. 6-6
Open Access
Multifaceted Approaches in Epithelial Cell Adhesion Molecule-Mediated Circulating Tumor Cell Isolation
Dóra Szerényi, Gábor Járvás, András Guttman
Molecules (2025) Vol. 30, Iss. 5, pp. 976-976
Open Access
Dóra Szerényi, Gábor Járvás, András Guttman
Molecules (2025) Vol. 30, Iss. 5, pp. 976-976
Open Access
Pan-immune-inflammation in colon cancer: A prognostic biomarker and the role of tumor location in personalized care
Gaya Spolverato, Giulia Capelli, Floriane Noël, et al.
World Journal of Gastrointestinal Surgery (2025) Vol. 17, Iss. 4
Closed Access
Gaya Spolverato, Giulia Capelli, Floriane Noël, et al.
World Journal of Gastrointestinal Surgery (2025) Vol. 17, Iss. 4
Closed Access
The prognostic impact of tumor mutations and tumor-infiltrating lymphocytes in patients with localized pMMR colorectal cancer – a systematic review and meta-analysis
A. Nielsen, Ida Kolukisa Saqi, Tobias Freyberg Justesen, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104714-104714
Closed Access
A. Nielsen, Ida Kolukisa Saqi, Tobias Freyberg Justesen, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104714-104714
Closed Access
Molecular insights from comprehensive genomic profiling data in advanced metastatic colorectal cancer in South Asian population: A retrospective observational study
Nusrath Fathima, Krithika Verma, Paridhy Vanniya Subramanyam, et al.
Cancer Research Statistics and Treatment (2024) Vol. 7, Iss. 2, pp. 193-205
Open Access | Times Cited: 2
Nusrath Fathima, Krithika Verma, Paridhy Vanniya Subramanyam, et al.
Cancer Research Statistics and Treatment (2024) Vol. 7, Iss. 2, pp. 193-205
Open Access | Times Cited: 2
Receptor Pharmacogenomics: Deciphering Genetic Influence on Drug Response
Sorina Andreea Anghel, Cristina-Elena Dinu-Pîrvu, Mihaela-Andreea Costache, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9371-9371
Open Access | Times Cited: 2
Sorina Andreea Anghel, Cristina-Elena Dinu-Pîrvu, Mihaela-Andreea Costache, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9371-9371
Open Access | Times Cited: 2
USP21-EGFR signaling axis is functionally implicated in metastatic colorectal cancer
Ji Hye Shin, Mi‐Jeong Kim, JY Kim, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Ji Hye Shin, Mi‐Jeong Kim, JY Kim, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Anti-epidermal growth factor receptor treatment for patients with NeoRAS wild-type metastatic colorectal cancer: a case report of two cases
Kazuaki Harada, Satoshi Yuki, Yasuyuki Kawamoto, et al.
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 5
Kazuaki Harada, Satoshi Yuki, Yasuyuki Kawamoto, et al.
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 5
Predictive role of [18F]FDG PET-CT radiomic parameters for KRAS/BRAF/EGFR mutations in metastatic colorectal cancer patients
Magdi A. Ali, Omar Shebl Zahra, Mohamed Morsi, et al.
Deleted Journal (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Magdi A. Ali, Omar Shebl Zahra, Mohamed Morsi, et al.
Deleted Journal (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Systemic Therapy for Metastatic Colon Cancer: New Frontiers
Yoanna S Pumpalova
Clinics in Colon and Rectal Surgery (2024) Vol. 38, Iss. 03, pp. 229-236
Closed Access
Yoanna S Pumpalova
Clinics in Colon and Rectal Surgery (2024) Vol. 38, Iss. 03, pp. 229-236
Closed Access
USP21-EGFR signaling axis is functionally implicated in metastatic colorectal cancer
Ki‐Young Lee, Ji Hye Shin, Mi‐Jeong Kim, et al.
Research Square (Research Square) (2024)
Open Access
Ki‐Young Lee, Ji Hye Shin, Mi‐Jeong Kim, et al.
Research Square (Research Square) (2024)
Open Access
First-Line Therapy in Metastatic, RAS Wild-Type, Left-Sided Colorectal Cancer: Should Everyone Receive Anti-EGFR Therapy?
Marco Airoldi, Michela Bartolini, Roberta Fazio, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 11, pp. 1489-1501
Closed Access
Marco Airoldi, Michela Bartolini, Roberta Fazio, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 11, pp. 1489-1501
Closed Access
In-Silico Network Pharmacology and Molecular Docking Study of Homeopathic Preparation of Ruta Graveolens Q on Colorectal Cancer
V. Kumaravel, Prasenjit Pal, Susanta Pal, et al.
(2024)
Closed Access
V. Kumaravel, Prasenjit Pal, Susanta Pal, et al.
(2024)
Closed Access
Bevacizumab mitigates codon-specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer
Bernhard Doleschal, Hossein Taghizadeh, Theresa Lentner, et al.
ESMO Open (2023) Vol. 8, Iss. 6, pp. 102064-102064
Open Access | Times Cited: 1
Bernhard Doleschal, Hossein Taghizadeh, Theresa Lentner, et al.
ESMO Open (2023) Vol. 8, Iss. 6, pp. 102064-102064
Open Access | Times Cited: 1
